FDA Approves New Type of Antibiotic for Gonorrhea, First in Decades

(MedPage Today) — The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday.
Gepotidacin is the first in a new class of antibiotics…